Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?

Free article

Comment

Tajinder P Singh et al. J Am Coll Cardiol. 2010.

Free article

. 2010 Aug 31;56(10):823; author reply 823-4.

doi: 10.1016/j.jacc.2010.04.037.

No abstract available

Comment on

The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
Kantor PF, Abraham JR, Dipchand AI, Benson LN, Redington AN. Kantor PF, et al. J Am Coll Cardiol. 2010 Mar 30;55(13):1377-84. doi: 10.1016/j.jacc.2009.11.059. J Am Coll Cardiol. 2010. PMID: 20338500

Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M, Hara Y, Ohtsuka T, Suzuki J, Saeki H, Ogimoto A, Shigematsu Y. Hamada M, et al. J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S5-10. J Cardiovasc Pharmacol. 2003. PMID: 12688389
Current management of pediatric dilated cardiomyopathy.
Silva JN, Canter CE. Silva JN, et al. Curr Opin Cardiol. 2010 Mar;25(2):80-7. doi: 10.1097/HCO.0b013e328335b220. Curr Opin Cardiol. 2010. PMID: 20019605 Review.
[Should beta-adrenergic blockade be part of drug therapy for heart failure?].
Leinonen H. Leinonen H. Duodecim. 1995;111(3):209-13. Duodecim. 1995. PMID: 8654281 Review. Finnish. No abstract available.
[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Campa PP, Puddu PE, Schiariti M, Monti F, Dawodu AA, Gentile C, Lilla Della Monica PL, Vaccaro M, De Biase L. Campa PP, et al. Cardiologia. 1995 Dec;40(12 Suppl 1):139-50. Cardiologia. 1995. PMID: 8998706 Italian. No abstract available.
Up to date in pharmacological treatment of dilated cardiomyopathy.
Ginghina C, Teodorescu A, Stoian I, Serban M, Ghiorghiu I, Wohlfart K. Ginghina C, et al. Rom J Intern Med. 2004;42(1):3-13. Rom J Intern Med. 2004. PMID: 15529591 Review.